Fallopia japonica, a Natural Modulator, Can Overcome Multidrug Resistance in Cancer Cells

Area of Science:

• Pharmacology
• Natural Products Chemistry
• Cancer Biology

Background:

• Multidrug resistance (MDR) in cancer cells hinders chemotherapy efficacy.
• ATP-binding cassette (ABC) transporters and metabolic enzymes are key mediators of MDR.
• Natural products offer a promising avenue for discovering novel MDR inhibitors.

Purpose of the Study:

• To investigate the potential of Traditional Chinese Medicine (TCM) extracts in overcoming MDR.
• To characterize the interaction of TCM extracts with ABC transporters, cytochrome P3A4 (CYP3A4), and glutathione-S-transferase (GST).
• To evaluate the cytotoxic effects of promising TCM extracts on various cancer cell lines.

Main Methods:

• Screening of 16 TCM plant extracts for MDR-related activities.
• Assays for ABC transporter (P-glycoprotein), CYP3A4, and GST inhibition.
• Cytotoxicity assessment using IC50 values in Caco-2, HepG-2, and HeLa cell lines.
• Liquid chromatography-electrospray ionization-mass spectrometry (LC-ESI-MS) for compound identification.

Main Results:

• Fallopia japonica (FJ) extract demonstrated potent inhibition of CYP3A4 P-glycoprotein activity, exceeding the positive control verapamil.
• FJ extract significantly inhibited GST activity and showed comparable efficacy to ketoconazole.
• FJ exhibited moderate cytotoxicity against Caco-2, HepG-2, and HeLa cell lines with specific IC50 values.
• Emodin, polydatin, and resveratrol were identified as major compounds in the active FJ extract.

Conclusions:

• Fallopia japonica extract shows significant potential as a natural product to modulate ABC drug transporter function and combat MDR.
• The identified compounds (emodin, polydatin, resveratrol) are key contributors to FJ's MDR-inhibitory effects.
• Further research is warranted to explore the therapeutic application of FJ's active metabolites in overcoming chemotherapy failure.